Kyverna

Autoimmune diseases occur when certain immune cells trigger an attack on a person’s own “self” tissue. Rather than suppressing the whole immune system (and leaving the patient vulnerable to infection), Kyverna’s team is reprogramming T cells to selectively eliminate these autoreactive cells. This pioneering approach mimics the normal checks and balances that occur within a healthy immune system.